Literature DB >> 22421338

The interleukin-6 pathway and atherosclerosis.

S Matthijs Boekholdt1, Erik S G Stroes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22421338     DOI： 10.1016/S0140-6736(12)60361-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Physical Function and Strength in Relation to Inflammation in Older Adults with Obesity and Increased Cardiometabolic Risk.

Authors:  J Tay; A M Goss; J L Locher; J D Ard; B A Gower
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 2.  The varying faces of IL-6: From cardiac protection to cardiac failure.

Authors:  Jillian A Fontes; Noel R Rose; Daniela Čiháková
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

3.  Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension.

Authors:  Andrew W Johnson; Dale A Kinzenbaw; Mary L Modrick; Frank M Faraci
Journal:  Hypertension       Date:  2012-12-24       Impact factor: 10.190

Review 4.  IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.

Authors:  Stefan Rose-John
Journal:  Int J Biol Sci       Date:  2012-10-24       Impact factor: 6.580

5.  Interleukin-6 May Contribute to Mortality in Parkinson's Disease Patients: A 4-Year Prospective Study.

Authors:  Michal Dufek; Irena Rektorova; Vojtech Thon; Jindrich Lokaj; Ivan Rektor
Journal:  Parkinsons Dis       Date:  2015-08-16

6.  Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.

Authors:  Ekim Seven; Lise L N Husemoen; Thomas S G Sehested; Hans Ibsen; Kristian Wachtell; Allan Linneberg; Jørgen L Jeppesen
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

7.  Interleukin-10 protects against aging-induced endothelial dysfunction.

Authors:  Dale A Kinzenbaw; Yi Chu; Ricardo A Peña Silva; Sean P Didion; Frank M Faraci
Journal:  Physiol Rep       Date:  2013-11-11

Review 8.  Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.

Authors:  Toshio Tanaka; Tadamitsu Kishimoto
Journal:  Int J Biol Sci       Date:  2012-10-24       Impact factor: 6.580

Review 9.  Interleukin-6 receptor pathways in abdominal aortic aneurysm.

Authors:  Seamus C Harrison; Andrew J P Smith; Gregory T Jones; Daniel I Swerdlow; Riaz Rampuri; Matthew J Bown; Lasse Folkersen; Annette F Baas; Gert Jan de Borst; Jan D Blankensteijn; Jacqueline F Price; Yolanda van der Graaf; Stela McLachlan; Obi Agu; Albert Hofman; Andre G Uitterlinden; Anders Franco-Cereceda; Ynte M Ruigrok; F N van't Hof; Janet T Powell; Andre M van Rij; Juan P Casas; Per Eriksson; Michael V Holmes; Folkert W Asselbergs; Aroon D Hingorani; Steve E Humphries
Journal:  Eur Heart J       Date:  2012-10-30       Impact factor: 29.983

10.  Interleukin-6 receptor rs7529229 T/C polymorphism is associated with left main coronary artery disease phenotype in a Chinese population.

Authors:  Feng He; Xiao Teng; Haiyong Gu; Hanning Liu; Zhou Zhou; Yan Zhao; Shengshou Hu; Zhe Zheng
Journal:  Int J Mol Sci       Date:  2014-04-02       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.